|
461 |
Pharmacotherapy for Hepatic Encephalopathy
Enthalten in Drugs Bd. 70, 19.9.2012, Nr. 9, date:6.2010: 1131-1148
|
|
|
|
462 |
Pharmacotherapy for Prevention and Treatment of Acute Respiratory Distress Syndrome
Enthalten in Drugs Bd. 70, 19.9.2012, Nr. 10, date:7.2010: 1255-1282
|
|
|
|
463 |
Pharmacotherapy in Pediatric Critical Illness
Enthalten in Pediatric drugs Bd. 11, 22.8.2012, Nr. 5, date:10.2009: 323-331
|
|
|
|
464 |
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents
Enthalten in Drugs Bd. 72, 12.12.2012, Nr. 3, date:2.2012: 309-325
|
|
|
|
465 |
Pharmacotherapy of Epilepsy
Enthalten in CNS drugs Bd. 25, 29.8.2012, Nr. 2, date:2.2011: 89-107
|
|
|
|
466 |
Pharmacovigilance Activities in Nepal
Enthalten in Drug safety Bd. 33, 9.1.2013, Nr. 10, date:10.2010: 889-890
|
|
|
|
467 |
Pharmacovigilance of Biopharmaceuticals
Enthalten in Drug safety Bd. 32, 30.12.2012, Nr. 10, date:10.2009: 811-817
|
|
|
|
468 |
Pharmacy Compounding Primer for Physicians
Enthalten in Drugs Bd. 72, 25.12.2012, Nr. 16, date:12.2012: 2043-2050
|
|
|
|
469 |
Phase I Clinical Studies of the Advanced Glycation End-product (AGE)-Breaker TRC4186
Enthalten in Clinical drug investigation Bd. 29, 24.8.2012, Nr. 9, date:9.2009: 559-575
|
|
|
|
470 |
Phase I Clinical Study of Edaravone in Healthy Chinese Volunteers
Enthalten in Drugs in R & D Bd. 12, 18.12.2012, Nr. 2, date:6.2012: 65-70
|
|
Administration
